Enovix (NASDAQ:ENVX) Shares Down 7.1% – Should You Sell?

Shares of Enovix Corporation (NASDAQ:ENVX) fell 7.1% during trading on Wednesday . The company traded as low as $8.13 and last traded at $8.0650. 952,123 shares changed hands during trading, a decline of 82% from the average session volume of 5,307,417 shares. The stock had previously closed at $8.68.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on ENVX shares. JPMorgan Chase & Co. decreased their price target on shares of Enovix from $12.00 to $10.00 and set a “neutral” rating for the company in a research note on Wednesday, November 12th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Enovix in a research note on Monday, December 29th. Cantor Fitzgerald dropped their price target on Enovix from $30.00 to $25.00 and set an “overweight” rating on the stock in a research report on Thursday, November 6th. Northland Securities set a $16.00 price target on Enovix in a research note on Monday, November 17th. Finally, Canaccord Genuity Group lowered their price objective on Enovix from $22.00 to $21.00 and set a “buy” rating for the company in a research note on Thursday, November 6th. Five research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $17.50.

Enovix Stock Down 2.1%

The company has a market cap of $1.71 billion, a P/E ratio of -9.77 and a beta of 2.13. The company’s 50-day moving average is $8.37 and its two-hundred day moving average is $10.33. The company has a debt-to-equity ratio of 1.74, a current ratio of 9.72 and a quick ratio of 9.47.

Enovix (NASDAQ:ENVX) last issued its earnings results on Tuesday, September 9th. The company reported ($0.13) EPS for the quarter. Enovix had a negative net margin of 525.93% and a negative return on equity of 61.78%. The business had revenue of $7.47 million for the quarter. Enovix has set its Q4 2025 guidance at -0.200–0.160 EPS. As a group, equities analysts predict that Enovix Corporation will post -1.01 earnings per share for the current fiscal year.

Institutional Trading of Enovix

A number of large investors have recently made changes to their positions in ENVX. Caitlin John LLC bought a new position in Enovix during the third quarter valued at approximately $27,000. Parallel Advisors LLC lifted its holdings in shares of Enovix by 51.9% during the 3rd quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock valued at $39,000 after buying an additional 1,342 shares during the period. Stone House Investment Management LLC boosted its stake in shares of Enovix by 56.4% in the 3rd quarter. Stone House Investment Management LLC now owns 7,922 shares of the company’s stock worth $79,000 after buying an additional 2,857 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new stake in shares of Enovix in the third quarter worth $80,000. Finally, Integrity Alliance LLC. purchased a new stake in Enovix during the first quarter valued at $98,000. 50.92% of the stock is currently owned by institutional investors.

Enovix Company Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.